drug
lomitapide
Marketedupdated 3mo agoby Chiesi USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying lomitapide
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 19, 2027
~1.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Jul 29, 2041method-of-use (U-4438)US 12472172
- Jul 29, 2041method-of-use (U-4438)US 12472172
- Jul 29, 2041method-of-use (U-4438)US 12472172
- Jul 29, 2041method-of-use (U-4438)US 12472172
- Jul 29, 2041method-of-use (U-4438)US 12472172
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
- Aug 19, 2027method-of-use (U-1316)US 79322681.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that